Status:
UNKNOWN
FDG-PET in the Diagnosis of Autoimmune Encephalitis
Lead Sponsor:
University of Milano Bicocca
Conditions:
Autoimmune Encephalitis
Eligibility:
All Genders
Brief Summary
The goal of this retrospective observational study is to compare brain fluorodeoxyglucose-positron emission tomography (FDG-PET) of patients with autoimmune encephalitis, normal controls and patients ...
Eligibility Criteria
Inclusion
- Diagnosis of autoimmune encephalitis according to clinical criteria
- Brain magnetic resonance imaging performed between clinical presentation and treatment
- Cerebrospinal fluid analysis performed between clinical presentation and treatment
- Brain FDG-PET performed between clinical presentation and treatment
- Autoantibodies testing performed between clinical presentation and treatment
Exclusion
- Refusal to give consent for the study
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06019975
Start Date
March 1 2023
End Date
April 30 2024
Last Update
January 2 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Sanitaria Universitaria Friuli Centrale
Udine, Friuli Venezia Giulia, Italy
2
IRCCS Ospedale Policlinico San Martino
Genoa, Liguria, Italy
3
Fondazione IRCCS Mondino
Pavia, Lombardy, Italy
4
Fondazione IRCCS San Gerardo dei Tintori
Monza, Monza E Della Brianza, Italy, 20900